GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Gross-Profit-to-Asset %

Imricor Medical Systems (ASX:IMR) Gross-Profit-to-Asset % : -9.08% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Imricor Medical Systems's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$-1.11 Mil. Imricor Medical Systems's average Total Assets over the quarter that ended in Dec. 2023 was A$12.26 Mil. Therefore, Imricor Medical Systems's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was -9.08%.


Imricor Medical Systems Gross-Profit-to-Asset % Historical Data

The historical data trend for Imricor Medical Systems's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Gross-Profit-to-Asset % Chart

Imricor Medical Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 2.02 -1.77 -6.46 -7.82 -10.19

Imricor Medical Systems Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only -9.02 -7.84 -8.82 -13.65 -9.08

Competitive Comparison of Imricor Medical Systems's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Imricor Medical Systems's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imricor Medical Systems's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Imricor Medical Systems's Gross-Profit-to-Asset % falls into.



Imricor Medical Systems Gross-Profit-to-Asset % Calculation

Imricor Medical Systems's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-1.667/( (20.305+12.412)/ 2 )
=-1.667/16.3585
=-10.19 %

Imricor Medical Systems's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-1.114/( (12.115+12.412)/ 2 )
=-1.114/12.2635
=-9.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Imricor Medical Systems Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Imricor Medical Systems (ASX:IMR) Business Description

Traded in Other Exchanges
N/A
Address
400 Gateway Boulevard, Burnsville, MN, USA, 55337
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines